ETS fusion genes in prostate cancer

被引：65

作者：

Tandefelt, Delila Gasi ^{[1
]}

Boormans, Joost ^{[2
]}

Hermans, Karin ^{[1
]}

Trapman, Jan ^{[1
]}

机构：

[1] Erasmus Univ, Med Ctr, Dept Pathol, NL-2000 CA Rotterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Urol, NL-2000 CA Rotterdam, Netherlands

来源：

关键词：

prostate cancer; gene fusion; androgen regulation; ETS gene; prostate specific; translocation; TMPRSS2-ERG FUSION; TRANSCRIPTION FACTORS; ANDROGEN-RECEPTOR; CLINICAL-IMPLICATIONS; FAVORABLE PROGNOSIS; ERG EXPRESSION; REARRANGEMENTS; ETV1; HETEROGENEITY; OVEREXPRESSION;

D O I：

10.1530/ERC-13-0390

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Prostate cancer is very common in elderly men in developed countries. Unravelling the molecular and biological processes that contribute to tumor development and progressive growth, including its heterogeneity, is a challenging task. The fusion of the genes ERG and TMPRSS2 is the most frequent genomic alteration in prostate cancer. ERG is an oncogene that encodes a member of the family of ETS transcription factors. At lower frequency, other members of this gene family are also rearranged and overexpressed in prostate cancer. TMPRSS2 is an androgen-regulated gene that is preferentially expressed in the prostate. Most of the less frequent ETS fusion partners are also androgen-regulated and prostate-specific. During the last few years, novel concepts of the process of gene fusion have emerged, and initial experimental results explaining the function of the ETS genes ERG and ETV1 in prostate cancer have been published. In this review, we focus on the most relevant ETS gene fusions and summarize the current knowledge of the role of ETS transcription factors in prostate cancer. Finally, we discuss the clinical relevance of TMRPSS2-ERG and other ETS gene fusions in prostate cancer.

引用

页码：R143 / R152

页数：10

共 85 条

[1] Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE) [J].

Allen, Marianne Lindahl ;

Antoniou, Michael .

EPIGENETICS, 2007, 2 (04) :227-236

[2] Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing [J].

Antoniou, M ;

Harland, L ;

Mustoe, T ;

Williams, S ;

Holdstock, J ;

Yague, E ;

Mulcahy, T ;

Griffiths, M ;

Edwards, S ;

Ioannou, PA ;

Mountain, A ;

Crombie, R .

GENOMICS, 2003, 82 (03) :269-279

[3] Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer [J].

Attard, G. ;

Clark, J. ;

Ambroisine, L. ;

Mills, I. G. ;

Fisher, G. ;

Flohr, P. ;

Reid, A. ;

Edwards, S. ;

Kovacs, G. ;

Berney, D. ;

Foster, C. ;

Massie, C. E. ;

Fletcher, A. ;

De Bono, J. S. ;

Scardino, P. ;

Cuzick, J. ;

Cooper, C. S. .

BRITISH JOURNAL OF CANCER, 2008, 99 (02) :314-320

[4] Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer [J].

Attard, G. ;

Clark, J. ;

Ambroisine, L. ;

Fisher, G. ;

Kovacs, G. ;

Flohr, P. ;

Berney, D. ;

Foster, C. S. ;

Fletcher, A. ;

Gerald, W. L. ;

Moller, H. ;

Reuter, V. ;

De Bono, J. S. ;

Scardino, P. ;

Cuzick, J. ;

Cooper, C. S. .

ONCOGENE, 2008, 27 (03) :253-263

[5] Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer [J].

Attard, Gerhardt ;

Swermenhuis, Joost F. ;

Olmos, David ;

Reid, Alison H. M. ;

Vickers, Elaine ;

A'Hern, Roger ;

Levink, Rianne ;

Coumans, Frank ;

Moreira, Joana ;

Riisnaes, Ruth ;

Oommen, Nikhil Babu ;

Hawche, George ;

Jameson, Charles ;

Thompson, Emilda ;

Sipkema, Ronald ;

Carden, Craig P. ;

Parker, Christopher ;

Dearnaley, David ;

Kaye, Stan B. ;

Cooper, Colin S. ;

Molina, Arturo ;

Cox, Michael E. ;

Terstappen, Leon W. M. M. ;

de Bono, Johann S. .

CANCER RESEARCH, 2009, 69 (07) :2912-2918

[6] ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients [J].

Baena, Esther ;

Shao, Zhen ;

Linn, Douglas E. ;

Glass, Kimberly ;

Hamblen, Melanie J. ;

Fujiwara, Yuko ;

Kim, Jonghwan ;

Minh Nguyen ;

Zhang, Xin ;

Godinho, Frank J. ;

Bronson, Roderick T. ;

Mucci, Lorelei A. ;

Loda, Massimo ;

Yuan, Guo-Cheng ;

Orkin, Stuart H. ;

Li, Zhe .

GENES & DEVELOPMENT, 2013, 27 (06) :683-698

[7] Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer [J].

Barbieri, Christopher E. ;

Baca, Sylvan C. ;

Lawrence, Michael S. ;

Demichelis, Francesca ;

Blattner, Mirjam ;

Theurillat, Jean-Philippe ;

White, Thomas A. ;

Stojanov, Petar ;

Van Allen, Eliezer ;

Stransky, Nicolas ;

Nickerson, Elizabeth ;

Chae, Sung-Suk ;

Boysen, Gunther ;

Auclair, Daniel ;

Onofrio, Robert C. ;

Park, Kyung ;

Kitabayashi, Naoki ;

MacDonald, Theresa Y. ;

Sheikh, Karen ;

Vuong, Terry ;

Guiducci, Candace ;

Cibulskis, Kristian ;

Sivachenko, Andrey ;

Carter, Scott L. ;

Saksena, Gordon ;

Voet, Douglas ;

Hussain, Wasay M. ;

Ramos, Alex H. ;

Winckler, Wendy ;

Redman, Michelle C. ;

Ardlie, Kristin ;

Tewari, Ashutosh K. ;

Mosquera, Juan Miguel ;

Rupp, Niels ;

Wild, Peter J. ;

Moch, Holger ;

Morrissey, Colm ;

Nelson, Peter S. ;

Kantoff, Philip W. ;

Gabriel, Stacey B. ;

Golub, Todd R. ;

Meyerson, Matthew ;

Lander, Eric S. ;

Getz, Gad ;

Rubin, Mark A. ;

Garraway, Levi A. .

NATURE GENETICS, 2012, 44 (06) :685-U107

[8] TMPRSS2-ERG fusion heterogeneity in Multifocal prostate cancer: Clinical and biologic implications [J].

Barry, Marc ;

Perner, Sven ;

Demichelis, Francesca ;

Rubin, Mark A. .

UROLOGY, 2007, 70 (04) :630-633

[9] ETV6: A versatile player in leukemogenesis [J].

Bohlander, SK .

SEMINARS IN CANCER BIOLOGY, 2005, 15 (03) :162-174

[10] Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer [J].

Boormans, Joost L. ;

Korsten, Hanneke ;

Ziel-van der Made, Angelique J. C. ;

van Leenders, Geert J. L. H. ;

de Vos, Carola V. ;

Jenster, Guido ;

Trapman, Jan .

INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (02) :335-345

← 1 2 3 4 5 6 7 8 9 →